Los Angeles Capital Management’s Arbutus Biopharma ABUS Stock Holding History
Bought
Maintained
Sold
Other funds holding ABUS
TSC
WCM
RCMNY
Los Angeles Capital Management's ABUS Position: Q2 2026 in Review
Los Angeles Capital Management opened a new position in Arbutus Biopharma (ABUS) in Q2 2026: 602,008 shares worth $2.89M. The stake represents 0.01% of the portfolio and ranks #520 among its holdings. This is a return to the name: Los Angeles Capital Management previously reported a position in ABUS as recently as Q4 2025.
Los Angeles Capital Management first reported a position in ABUS in Q2 2025 and has held it in 3 quarters since. 176 funds tracked by Wall St. Rank hold ABUS as of Q2 2026.
- Los Angeles Capital Management held 602,008 shares of Arbutus Biopharma worth $2.89M as of Q2 2026.
- Arbutus Biopharma was a new Los Angeles Capital Management position in Q2 2026.
- Arbutus Biopharma made up 0.01% of Los Angeles Capital Management's portfolio in Q2 2026, its #520 holding.
- Los Angeles Capital Management first reported a position in Arbutus Biopharma in Q2 2025 and has held it in 3 quarters since.
- 176 funds tracked by Wall St. Rank held Arbutus Biopharma as of Q2 2026.
Based on Los Angeles Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.